Switch of open-source automated insulin delivery system - AndroidAPS to commercially available AID systems in type 1 diabetes: the extension of the CODIAC study

被引：0
|
作者：
Do, D. Q. [1 ]
Haskova, A. [1 ]
Radovnicka, L. [2 ]
Horova, E. [3 ,4 ]
Konecna, J. [2 ]
Grunberger, G. [5 ]
Parkin, C. [6 ]
Prazny, M. [1 ]
Soupal, J. [1 ]
机构：
[1] Charles Univ Prague, Dept Internal Med 3, Fac Med 1, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Prague, Czech Republic
[3] Charles Univ Prague, Dept Internal Med 3, Fac Med 1, Prague 2, Czech Republic
[4] Gen Univ, Prague 2, Czech Republic
[5] Grunberger Diabet Inst, Bloomfield Hills, MI USA
[6] CGParkin Commun Inc, Res & Educ, Henderson, NV USA
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
772
引用
收藏
页码：S369 / S369
页数：1
相关论文
共 50 条
  • [41] The CREATE Trial: Randomized Clinical Trial Comparing Open-Source Automated Insulin Delivery with Sensor Augmented Pump Therapy in Type 1 Diabetes
    Burnside, Mercedes J.
    Lewis, Dana M.
    Crocket, Hamish
    Meier, Renee
    Williman, Jonathan
    Sanders, Olivia J.
    Jefferies, Craig A.
    Faherty, Ann M.
    Paul, Ryan
    Lever, Claire S.
    Wheeler, Benjamin J.
    Jones, Shirley
    Frewen, Carla M.
    Gunn, Tim
    Lampey, Christina
    De Bock, Martin
    DIABETES, 2022, 71
  • [42] OPEN SOURCE AUTOMATED INSULIN DELIVERY SYSTEMS: BENEFITS, LIMITATIONS AND CHALLENGES IN DIABETES CARE
    Shishin, Konstantin S.
    Klimontov, Vadim V.
    DIABETES MELLITUS, 2023, 26 (04): : 352 - 362
  • [43] Review of a commercially available hybrid closed-loop insulin-delivery system in the treatment of Type 1 diabetes
    Stone, Jenine Y.
    Haviland, Nalani
    Bailey, Timothy S.
    THERAPEUTIC DELIVERY, 2018, 9 (02) : 77 - 87
  • [44] Automated insulin delivery systems and vascular reactivity in type 1 diabetes: a prospective study
    Lupoli, R.
    Petrosino, C. P.
    Rainone, C.
    Vallefuoco, G.
    Calcaterra, I. L.
    Di Minno, M. N. D.
    Bozzetto, L.
    DIABETOLOGIA, 2024, 67 : S23 - S24
  • [45] CREATE (COMMUNITY DERIVED AUTOMATED INSULIN DELIVERY): RANDOMISED TRIAL COMPARING AUTOMATED INSULIN DELIVERY (ANYDANA-LOOP) USING OPEN-SOURCE ALGORITHM, WITH SENSOR AUGMENTED PUMP THERAPY IN TYPE 1 DIABETES
    Burnside, M.
    De Bock, M.
    Williman, J.
    Lewis, D.
    Jefferies, C.
    Crocket, H.
    Wheeler, B.
    Paul, R.
    Wilson, R.
    Sanders, O.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A74 - A74
  • [46] Re-framing type 1 diabetes care through open-source automated insulin delivery: 'The (expert) patient will see you now, doctor'
    Dinneen, Sean F.
    McMorrow, Liam
    DIABETIC MEDICINE, 2022, 39 (05)
  • [47] Real-world efficacy and safety of open-source automated insulin delivery for people with type 1 diabetes mellitus: Experience from mainland China
    Zhou, Yongwen
    Lei, Mengyun
    Yang, Daizhi
    Ling, Ping
    Ni, Ying
    Deng, Hongrong
    Xu, Wen
    Yang, Xubin
    Wheeler, Benjamin John
    Weng, Jianping
    Yan, Jinhua
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 218
  • [48] AN OPEN-SOURCE COMPARATIVE STUDY ON AVAILABLE MODELS TO DESCRIBE THE INFLUENCE OF PHYSICAL ACTIVITY ON PATIENTS WITH TYPE 1 DIABETES
    Schatz, V.
    Eichenlaub, M.
    Schrills, T.
    Lueddeke, H. -J.
    Peuscher, H.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A178 - A178
  • [49] Impact of Hypoglycemia on Glucose Variability over Time for Individuals with Open-Source Automated Insulin Delivery Systems
    Shahid, Arsalan
    Lewis, Dana M.
    DIABETOLOGY, 2024, 5 (05): : 514 - 536
  • [50] Automated Insulin Delivery in Elderly with Type 1 Diabetes: A Prespecified Analysis of the Extension Phase
    Kudva, Yogish C.
    Henderson, Robert J.
    Kanapka, Lauren G.
    Weinstock, Ruth S.
    Rickels, Michael R.
    Pratley, Richard E.
    Chaytor, Naomi
    Janess, Kamille
    Desjardins, Donna
    Pattan, Vishwanath
    Peleckis, Amy J.
    Casu, Anna
    Rizvi, Shafaq Raza
    Bzdick, Suzan
    Whitaker, Keri J.
    Kamimoto, Jorge L. Jo
    Miller, Kellee
    Kollman, Craig
    Beck, Roy W.
    AIDE study group
    DIABETES TECHNOLOGY & THERAPEUTICS, 2025,
12345